ADHD Drug Abuse in Schools; Bizarre Ozempic Dreams; COVID Ups Diabetes Risk

— Health news and commentary from around the Web gathered by MedPage Today staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require subscriptions.

Up to one in four middle school or high school kids reported misusing prescription stimulants used to treat attention-deficit/hyperactivity disorder (ADHD). (JAMA Network Open)

The Supreme Court is expected to rule today on whether to restrict access to the abortion pill mifepristone (Mifeprex) while a lower court's decision works its way through the courts. (AP)

HHS Secretary Xavier Becerra violated the Hatch Act, a law restricting federal employees from political activities, when he advocated for the election of Sen. Alex Padilla (D-Calif.) at an event last fall, the Office of Special Counsel said. (Washington Post)

The World Health Organization condemned reported attacks in Sudan on health personnel, health facilities, and ambulances, which have led to at least three people killed and two injured.

Some people using semaglutide (Ozempic) have reported bizarre, celebrity-filled dreams. (Insider)

Teladoc has expanded its telehealth services to include obesity drug prescribing. (Reuters)

Vaccine messages that focused on protecting others in the community performed stronger than messages that urged viewers to protect themselves. (PNAS Nexus)

Insurance companies are starting to cover telehealth abortions. (New York Times)

The former 1-800 GET-THIN doctor was sentenced to 7 years in federal prison for fraudulently submitting nearly $120 million in claims. (KTLA)

Warning labels on restaurant menus reduced the likelihood that people ordered items with high added sugar. (American Journal of Preventive Medicine)

A Texas woman was charged with murder after being accused of punching a pregnant hospital worker, causing her to lose her unborn child. (NBC News)

Eisai and Biogen's new Alzheimer's drug lecanemab (Leqembi) doesn't show a net health benefit over current treatment options, drug price watchdog ICER said. (Axios)

Smartwatches may be able to detect early Parkinson's disease. (npj Parkinson's Disease)

The FDA expanded the indication for atogepant (Qulipta) to include chronic migraine prevention in adults, AbbVie announced.

The agency also granted marketing authorization to the NTX100 tonic motor activation system to reduce symptoms of primary moderate-to-severe restless legs syndrome.

Neuspera Medical said it received FDA clearance for its micro-implant system for peripheral nerve stimulation to manage chronic pain.

Fewer Americans are living in areas with unhealthy air, according to the American Lung Association's annual "State of the Air" report.

From 2017 through March 2020, about 35% of kids and 59% of adults used dietary supplements, data from the National Health and Nutrition Examination Survey showed.

SARS-CoV-2 infection was associated with a higher risk of diabetes, with risk rising for severe cases. (JAMA Network Open)

Evidence remains insufficient to determine the benefits and harms of visually screening asymptomatic patients for skin cancer, the U.S. Preventive Services Task Force said. (JAMA)

As the pandemic response winds down, the Biden administration is working on a plan to get COVID vaccines to uninsured people. (Politico)

A federal judge ruled that Mississippi must join other states in allowing religious exemptions for school-required vaccinations. (AP)

Actor Jamie Foxx is still in the hospital, a week after his daughter revealed he had been admitted following a "medical complication." (CNN)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow